Get it on Google Play

Nanox receives FDA clearance for TAP2D imaging enhancement capability

February 3, 2026 8:15 AM EST Send to a Friend
Nano-X Imaging Ltd (NASDAQ: NNOX) announced that the U.S. Food and Drug Administration granted 510(k) clearance for TAP2D, a new ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login